HWI group
Verena J. is a Pharmacovigilance Scientist at HWI group since 2021. Prior to this role, Verena worked at CRS Clinical Research Services for ten years, holding the positions of Associate Director Bioanalysis and Study Director. Verena was also a member of EBF - European Bioanalysis Forum from 2010 to 2015. With a background in chemistry and natural sciences, Verena holds a Graduate Chemist degree from FAU Erlangen-Nürnberg and a Doctor of Natural Sciences degree from The Julius Maximilians University of Würzburg. Verena was also a scholarship recipient from Studienstiftung des deutschen Volkes. At IBMP - Institute for Biomedical and Pharmaceutical Research, Verena worked as an Application Scientist in LC-MS/MS and ELISA, focusing on bioanalytics and quality control.
HWI group
With 150 colleagues at 3 sites in Ruelzheim, Frankfurt and Appenweier we look back on 30 years of experience. We offer a service portfolio ranging from product development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to drug safety and GxP services. Together with network partners, HWI also supports clinical and preclinical studies. Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules. Our purpose is with novel technologies and innovative services to drive the development of highly effective medicines for everyone to improve peoples lives. Imprint: https://www.hwi-group.de/en/imprint.html Data protection information: https://www.hwi-group.de/en/company/infocenter.html GTC: https://www.hwi-group.de/en/company/infocenter.html